Link to the Show / Show NotesArthritisCentral News and Views #3 (11 MB)
- The significance and implications of the FDA's approval of a new once a
month treatment for osteoporosis called Boniva is discussed
- Background information on the current bisphosphonates Fosamax and Actonel
is provided. Do you really need to switch? What about new patients recently
diagnosed with osteoporosis?
- The issue of prolotherapy in osteoarthritis of the knee--a response to
a subscriber's question.
- The dilemna of unproven forms of treatment and a warning about not spending
your "hard-earned" money on them.
- Before you get too "desperate," Dr. Rutstein wants you to make
sure that you have exhausted all approved and beneficial treatments.
